Stocks to Watch: IRFC, SBI Life, Reliance Industries Among Top 10 Equities in Focus Today

Indian Stock Market Outlook for February 26

The Indian stock market is expected to open higher on Thursday, February 26, driven by global market cues. The Nifty 50 index is trading near the 25,667 mark, approximately 39 points higher than the previous close of Nifty futures.

The domestic equity market closed slightly higher on Wednesday, with the Nifty 50 remaining above the 25,400 level. The Sensex gained 50.15 points, or 0.06%, to settle at 82,276.07, while the Nifty 50 advanced 57.85 points, or 0.23%, to close at 25,482.50.

Stocks to Watch

Read also: Treasury Yields Experience Largest Increase in Two Weeks Following Release of Labor Market Data

Several stocks are likely to remain in focus on Thursday, February 26, including:

• IRFC: State-owned Indian Railway Finance Corporation (IRFC) announced that the government will not exercise the oversubscription option in its Offer for Sale (OFS).
• SBI Life Insurance: The life insurance company has announced an interim dividend of ₹2.70 per equity share (27%) for FY26.
• Reliance Industries: Reliance Industries Limited (RIL) has stated that Reliance Enterprise Intelligence has become its step-down subsidiary following the allotment of 85.32 crore shares.
• Tata Capital: The non-banking financial company has approved a ₹650.02 crore rights issue of equity shares in favour of its parent, Tata Capital.
• Adani Ports: Adani Ports and Special Economic Zone announced the early outcome of its cash tender offers to buy back up to $495.1 million of overseas bonds.
• RVNL: The company has received a Letter of Award (LoA) from the National Mineral Development Corporation for the development of a township in Kirandul, Chhattisgarh, with the project valued at ₹371.69 crore.
• Lupin: The Goods & Services Tax Department of Maharashtra has initiated inspection and search proceedings at the registered office of pharmaceutical major Lupin.
• Vikram Solar: The company has stated that the direct financial impact of the recent preliminary anti-dumping and countervailing (AD/CVD) duties imposed by the United States is limited for the company.
• Zydus Lifesciences: The company intends to introduce the Semaglutide injection in India under the brand names SEMAGLYN, MASHEMA, and ALTERME, following the expiry of the patent.
• Aditya Infotech: In a block deal, Dixon Technologies offloaded a 3.8% stake in Aditya InfoTech for ₹661 crore. Motilal Oswal Mutual Fund and Kotak Mahindra Mutual Fund acquired shares worth ₹180 crore each.